Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.525
-0.205 (-4.33%)
Sep 10, 2026, 1:02 PM EDT - Market open
Cytek Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -80.58 | -66.54 | -6.02 | -12.15 | 2.58 | 3.05 |
Depreciation & Amortization | 11.9 | 11.98 | 10.49 | 9.23 | 5.66 | 1.24 |
Loss (Gain) From Sale of Assets | 0.36 | 0.42 | 0.06 | 0.01 | - | - |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.28 |
Loss (Gain) From Sale of Investments | -5.12 | -5.67 | -5.21 | -6.66 | -0.08 | - |
Loss (Gain) on Equity Investments | - | - | - | - | - | -0.04 |
Stock-Based Compensation | 21.37 | 24.59 | 26.85 | 22.05 | 16.6 | 6.59 |
Provision & Write-off of Bad Debts | 0.87 | 0.41 | -0.06 | 0.27 | 0.1 | - |
Other Operating Activities | 39.01 | 34.93 | -8.43 | 3.05 | 2.84 | 2.15 |
Change in Accounts Receivable | 4.88 | 0.37 | -5.43 | -7.33 | -19.74 | -12.37 |
Change in Inventory | -4.66 | -5.24 | 14.76 | 4.29 | -17.65 | -7.07 |
Change in Accounts Payable | 1.41 | 0.45 | 2.58 | -1.78 | 1.86 | -0.26 |
Change in Unearned Revenue | 2.8 | 3.6 | 3.74 | 6.52 | 9.41 | 10.01 |
Change in Other Net Operating Assets | 1.72 | -3.97 | -7.93 | -12.2 | -13.8 | 1.03 |
Operating Cash Flow | -6.04 | -4.69 | 25.38 | 5.28 | -12.23 | 4.63 |
Operating Cash Flow Growth | - | - | 380.57% | - | - | -69.45% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -6.04 | -4.08 | -3.53 | -4.65 | -9.75 | -4.36 |
Sale of Property, Plant & Equipment | 0.21 | 0.25 | 0.29 | - | - | - |
Cash Acquisitions | - | - | -0.47 | -45.13 | - | -16.63 |
Sale (Purchase) of Intangibles | -0.09 | -0.11 | -0.2 | -0.18 | -0.12 | - |
Investment in Securities | 2.95 | 14.06 | -79.06 | -43.94 | -46.04 | - |
Other Investing Activities | -0 | -0 | - | - | - | - |
Investing Cash Flow | -2.98 | 10.12 | -82.97 | -93.89 | -55.91 | -20.99 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 5.58 | 4.18 | - | 2.98 | - |
Total Debt Issued | 8.62 | 5.58 | 4.18 | - | 2.98 | - |
Short-Term Debt Repaid | - | - | - | - | - | -2.77 |
Long-Term Debt Repaid | - | -4.75 | -0.56 | -0.57 | -0.05 | - |
Total Debt Repaid | -5.57 | -4.75 | -0.56 | -0.57 | -0.05 | -2.77 |
Net Debt Issued (Repaid) | 3.05 | 0.84 | 3.62 | -0.57 | 2.93 | -2.77 |
Issuance of Common Stock | 1.63 | 1.47 | 2.72 | 3.32 | 2.79 | 216.33 |
Repurchase of Common Stock | -0.8 | -15.74 | -22.17 | -44.57 | -0.21 | - |
Other Financing Activities | 0 | 0 | - | - | - | - |
Financing Cash Flow | 3.88 | -13.43 | -15.82 | -41.81 | 5.51 | 213.56 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 3.51 | 0.11 | 4.53 | -1.45 | -2.49 | 1.3 |
Net Cash Flow | -1.62 | -7.89 | -68.89 | -131.87 | -65.12 | 198.5 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -12.08 | -8.77 | 21.85 | 0.63 | -21.98 | 0.27 |
Free Cash Flow Growth | - | - | 3352.45% | - | - | -98.05% |
Free Cash Flow Margin | -5.84% | -4.35% | 10.90% | 0.33% | -13.40% | 0.21% |
Free Cash Flow Per Share | -0.09 | -0.07 | 0.17 | 0.01 | -0.16 | 0.00 |
Levered Free Cash Flow | 9.3 | 4.33 | 37.88 | -1.34 | -23.76 | -6.21 |
Unlevered Free Cash Flow | 9.49 | 4.63 | 37.88 | -0.04 | -22.15 | -5.12 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | - | 2.16 | 3.83 | 5.31 | 10.39 | 2.86 |
Change in Working Capital | 6.15 | -4.79 | 7.71 | -10.51 | -39.93 | -8.65 |